v3.25.2
Organization and Description of Business Operations - Business Combination (Details)
$ / shares in Units, $ in Millions
1 Months Ended
Apr. 30, 2025
USD ($)
$ / shares
shares
Oct. 23, 2024
USD ($)
Nov. 30, 2022
USD ($)
shares
Mar. 31, 2025
$ / shares
Mar. 04, 2025
$ / shares
shares
Dec. 31, 2024
$ / shares
Dec. 31, 2023
$ / shares
Mar. 09, 2021
shares
Iris Acquisition Corp. ("Iris") (SPAC Company) | Subsequent Events                
Business Combination [Line Items]                
Common Stock, par value $ 0.0001              
Exercise price of warrants $ 11.5              
Iris Parent Holding Corp                
Business Combination [Line Items]                
Common Stock, par value       $ 0.0001   $ 0.0001 $ 0.0001  
Redeemable warrant | Iris Acquisition Corp. ("Iris") (SPAC Company) | Subsequent Events                
Business Combination [Line Items]                
Number of warrants held in each unit | shares 0.25              
Redeemable warrant | Iris Parent Holding Corp                
Business Combination [Line Items]                
Number of warrants held in each unit | shares         0.25      
Class A shares | Iris Acquisition Corp. ("Iris") (SPAC Company)                
Business Combination [Line Items]                
Common Stock, par value       $ 0.0001   $ 0.0001 $ 0.0001  
Number of shares per warrant | shares               1
Class A shares | Iris Acquisition Corp. ("Iris") (SPAC Company) | Subsequent Events                
Business Combination [Line Items]                
Number of shares held in each unit | shares 1              
Common Stock, par value $ 0.0001              
Class A shares | Iris Parent Holding Corp                
Business Combination [Line Items]                
Number of shares held in each unit | shares         1      
Common Stock, par value         $ 0.0001      
Class A shares | Non-redeemable warrant | Iris Acquisition Corp. ("Iris") (SPAC Company) | Subsequent Events                
Business Combination [Line Items]                
Number of shares per warrant | shares 1              
Exercise price of warrants $ 11.5              
LIMINATUS PHARMA, LLC | Iris Parent Holding Corp | Subsequent Events                
Business Combination [Line Items]                
Number of shares issued as business consideration, in exchange of acquiree's member units (in shares) | shares 17,500,000              
Deemed price per share $ 10              
LIMINATUS PHARMA, LLC | Forecast | Iris Acquisition Corp. ("Iris") (SPAC Company)                
Business Combination [Line Items]                
Number of shares issued as business consideration, in exchange of acquiree's member units (in shares) | shares     25,000,000          
Aggregate equity value of acquirer | $   $ 175.0 $ 250.0          
LIMINATUS PHARMA, LLC | Scenario where Iris Business Combination completed in accordance with the current terms of the agreement | Iris Acquisition Corp. ("Iris") (SPAC Company)                
Business Combination [Line Items]                
Minimum gross proceeds from equity subscriptions | $   $ 15.0            
Liminatus Pharma LLC And Iris Acquisition Corp | Iris Parent Holding Corp | Subsequent Events                
Business Combination [Line Items]                
Common Stock, par value $ 0.0001              
Business combination, conversion ratio 1              
Liminatus Pharma LLC And Iris Acquisition Corp | Class A shares                
Business Combination [Line Items]                
Aggregate equity value | $ $ 175.0